[HTML][HTML] A review of artificial intelligence applications in hematology management: current practices and future prospects

Y El Alaoui, A Elomri, M Qaraqe… - Journal of Medical …, 2022 - jmir.org
Background Machine learning (ML) and deep learning (DL) methods have recently
garnered a great deal of attention in the field of cancer research by making a noticeable …

Radiomics analysis for multiple myeloma: a systematic review with radiomics quality scoring

ME Klontzas, M Triantafyllou, D Leventis, E Koltsakis… - Diagnostics, 2023 - mdpi.com
Multiple myeloma (MM) is one of the most common hematological malignancies affecting the
bone marrow. Radiomics analysis has been employed in the literature in an attempt to …

New developments in myeloma treatment and response assessment

F Kraeber-Bodéré, B Jamet, D Bezzi… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Recent innovative strategies have dramatically redefined the therapeutic landscape for
treating multiple myeloma patients. In particular, the development and application of …

18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple …

H Zhong, D Huang, J Wu, X Chen, Y Chen… - BMC Medical Imaging, 2023 - Springer
Purpose Multiple myeloma (MM), the second most hematological malignancy, have been
studied extensively in the prognosis of the clinical parameters, however there are only a few …

Clinical value of FDG-PET/CT in multiple myeloma: an update

D Bezzi, V Ambrosini, C Nanni - Seminars in Nuclear Medicine, 2023 - Elsevier
FDG-PET/CT is a standardized imaging technique that has reached a great importance in
the management of patients affected by Multiple Myeloma. It is proved, in fact, that it allows a …

Collinearity and dimensionality reduction in Radiomics: effect of preprocessing parameters in hypertrophic cardiomyopathy magnetic resonance T1 and T2 mapping

C Marzi, D Marfisi, A Barucci, J Del Meglio, A Lilli… - Bioengineering, 2023 - mdpi.com
Radiomics and artificial intelligence have the potential to become a valuable tool in clinical
applications. Frequently, radiomic analyses through machine learning methods present …

Liquid biopsies and minimal residual disease in myeloid malignancies

S Allam, K Nasr, F Khalid, Z Shah… - Frontiers in …, 2023 - frontiersin.org
Minimal residual disease (MRD) assessment through blood component sampling by liquid
biopsies (LBs) is increasingly being investigated in myeloid malignancies. Blood …

[HTML][HTML] Advancements in Multiple Myeloma Research: High-Throughput Sequencing Technologies, Omics, and the Role of Artificial Intelligence

A Gutiérrez-González, I Del Hierro… - Biology, 2024 - mdpi.com
Multiple myeloma is a complex and challenging type of blood cancer that affects plasma
cells in the bone marrow. In recent years, the development of advanced research …

Current Status and Future of Artificial Intelligence in MM Imaging: A Systematic Review

E Alipour, A Pooyan, F Shomal Zadeh, AD Darbandi… - Diagnostics, 2023 - mdpi.com
Artificial intelligence (AI) has attracted increasing attention as a tool for the detection and
management of several medical conditions. Multiple myeloma (MM), a malignancy …

Segmentation agreement and the reliability of radiomics features

I Cama, V Candiani, L Roccatagliata… - Advances in …, 2023 - aimsciences.org
Radiomics features extracted from medical images have been shown to correlate with tumor
histological biomarkers and patient clinical information. An accurate selection of reliable …